DR.JAN CLAES
ActiveDR.JAN CLAES has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €143k and a net result of €99k. Equity is growing by ~51.5% per year across the filed fiscal years. Its solvency ranks better than 70% of 16511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 5.7 against 7.04 in 2024; short-term debt: 17.4% and cash: 44.1% of total assets), and 19.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
80.6%
Return on assets
55.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
58 d early
2024
7 d early
2023
7 d early
2022
7 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€143k▼ 41.4%
2024 · €244k
2022: €28k
2023: €131k
2024: €244k
2022 → 2025
Total assets
€178k▼ 37.8%
2024 · €286k
2022: €36k
2023: €167k
2024: €286k
2022 → 2025
Net result
€99k▼ 12.6%
2024 · €113k
2022: €18k
2023: €103k
2024: €113k
2022 → 2025
Working capital
€146k▼ 40.3%
2024 · €244k
2022: €27k
2023: €131k
2024: €244k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€28k-€131k▲ 364%€244k▲ 86.0%€143k▼ 41.4%
Operating result€23k-€134k▲ 476%€146k▲ 9.6%€129k▼ 11.9%
Net result€18k-€103k▲ 463%€113k▲ 9.6%€99k▼ 12.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 12% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €178k
Fixed assets
€1k=
Current assets
€177k▼ 37.9%
Equity and liabilities €178k
Equity
€143k▼ 41.4%
Debt
€35k▼ 16.0%
The debt ratio rises from 14.4% to 19.4%. Equity and debt are lower.
Key figures and ratios
Solvency
80.6%▼
2024 · 85.6%
Current ratio
5.70▼
2024 · 7.04
Quick ratio
5.70▼
2024 · 7.04
Debt / equity
0.24▲
2024 · 0.17
ROE
69.0%▲
2024 · 46.2%
ROA
55.6%▲
2024 · 39.6%
Debt
€35k▼
2024 · €41k
Debt ≤ 1 year
€31k▼
2024 · €40k
Income taxes
€30k▼
2024 · €34k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€286k€178k▼
Fixed assets21/28€1k€1k=
Financial fixed assets28€1k€1k=
Current assets29/58€285k€177k▼
Amounts receivable after more than one year29€10k€10k=
Other amounts receivable291€10k€10k=
Amounts receivable within one year40/41€40k€24k▼
Trade receivables40€30k€18k▼
Other amounts receivable41€10k€6k▼
Current investments50/53€114k€63k▼
Cash at bank and in hand54/58€120k€78k▼
Deferred charges and accrued income490/1€1k€997▼
Equity and liabilities
Total equity and liabilities10/49€286k€178k▼
Equity10/15€244k€143k▼
Contributions10/11€10k€10k=
Reserves13€234k€133k▼
Distributable reserves133€234k€133k▼
Amounts payable17/49€41k€35k▼
Amounts payable within one year42/48€40k€31k▼
Trade debts44€3k€3k▼
Suppliers440/4€3k€3k▼
Taxes, remuneration and social security45€35k€1k▼
Taxes450/3€35k€1k▼
Other amounts payable47/48€3k€27k▲
Accrued charges and deferred income492/3€690€4k▲
Income statement
Code20242025
Other operating charges640/8€1k€1k▲
Gross operating margin9900€147k€130k▼
Operating profit (loss)9901€146k€129k▼
Financial income75/76B€1k€3k▲
Recurring financial income75€1k€3k▲
Financial charges65/66B€456€3k▲
Recurring financial charges65€456€3k▲
Profit (loss) for the period before taxes9903€147k€129k▼
Income taxes67/77€34k€30k▼
Profit (loss) for the period9904€113k€99k▼
Profit (loss) for the period to be appropriated9905€113k€99k▼
Appropriation of the result
Profit (loss) to be appropriated9906€113k€99k▼
Transfer from equity791/2-€200k
Transfer to equity691/2€113k€99k▼
To other reserves6921€113k€99k▼
Profit to be distributed694/7-€200k
Return on contributions (dividend)694-€200k
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €113k ▲9.6%
Operating result €146k, net result €113k, both a record.
31-12
Financial
Equity above €200kEq €244k ▲86%
3 profitable years in a row build equity to €244k.
24-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €100kEq €131k ▲364%
2 profitable years in a row build equity to €131k.
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 2 establishment units since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Willy Mindersstraat 123600 GenkGround area
2,756 m²
Building footprint
372 m²
Volume, LiDAR
3,474 m³
2 parcels, Flanders · tallest building 23.2 m, ±7 floors. Linked by address, not a title deed.
2 establishment units
DR.JAN CLAES
since 20222.335.964.787
Dr. Jan Claes
since 20252.369.173.728
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73042D0800/00V000 | Flanders | 1,821 m² | 1 · 245 m² | 8.2 m · 1 fl. |
| 71303B0742/00K000 | Flanders | 935 m² | 1 · 127 m² | 23.2 m · 7 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR BERNARD MULDER
BE 0830.213.694
Oupeye · Eq €143k
Dr. Gert-Jan Aelvoet
BE 0714.886.931
Roeselare · Eq €143k
Dr. Liese De Smyter
BE 0754.378.797
Boechout · Eq €143k
DOCTEUR PIERRE LELUBRE
BE 0874.984.045
Tournai · Eq €143k
Dr. I. Rasschaert
BE 0888.602.152
Wetteren · Eq €143k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,452 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-09-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.